Sign Up to like & get
recommendations!
1
Published in 2019 at "Neurology and Therapy"
DOI: 10.1007/s40120-019-00162-7
Abstract: Fingolimod is the first orally administered drug approved for the treatment of relapsing–remitting multiple sclerosis (MS). This drug, modulating sphingosine receptors, regulates the trafficking of lymphocytes between primary and secondary lymphoid organs, trapping naïve T…
read more here.
Keywords:
beyond sequestration;
fingolimod immune;
memory cells;
fingolimod ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2019 at "PET clinics"
DOI: 10.1016/j.cpet.2019.06.007
Abstract: Interventional oncology treatments have profound effects on tumor immunity. Quantitative molecular imaging with FDG-PET has the potential to aid in understanding baseline tumor characteristics that can predict response to interventional oncology treatments and immunotherapy. This…
read more here.
Keywords:
pet assessment;
interventional oncology;
assessment immune;
effects interventional ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2018.01736
Abstract: Sepsis, a life-threatening organ dysfunction, results from a dysregulated host response to invading pathogens that may be characterized by overwhelming systemic inflammation or some sort of immune paralysis. Sepsis remains a major cause of morbidity…
read more here.
Keywords:
sepsis;
corticosteroids sepsis;
effects corticosteroids;
mortality ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Medicine"
DOI: 10.3389/fmed.2022.810189
Abstract: According to the result released by the World Health Organization (WHO), non-communicable diseases have occupied four of the top 10 current causes for death in the world. Cancer is one of the significant factors that…
read more here.
Keywords:
immune effects;
anesthetics intracellular;
systemic immune;
intracellular targets ... See more keywords